ChemicalBook >> CAS DataBase List >>3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo-

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo-

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- structure

CAS No.: 2580935-57-3

Chemical Name:: 3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo-

Synonyms: PTPN22-IN-1; (S)-6-(2-([1,1'-biphenyl]-4-ylcarboxamido)propanamido)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo-

CBNumber:: CB69824306

Molecular Formula:: C26H21N3O5

Molecular Weight:: 455.46

MDL Number:

MOL File:: 2580935-57-3.mol

Last updated:2024-07-02 08:55:14

Request For Quotation

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- Properties

Boiling point	767.5±60.0 °C(Predicted)
Density	1.370±0.06 g/cm3(Predicted)
storage temp.	Store at -20°C
form	Solid
pka	6.46±0.10(Predicted)
color	White to yellow

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- Chemical Properties,Uses,Production

Biological Activity

PTPN22-IN-1 is a potent PTPN22 inhibitor (IC50=1.4 μM; Ki=0.50 μM). PTPN22-IN-1 exhibits >7-10 fold selectivity for PTPN22 over similar phosphatases. PTPN22-IN-1 augments antitumor immune responses[1]. From WO2021007491A1 compound L-1. PTPN22-IN-1 (Compound L-1) (WT mice; intraperitoneally) significantly reduces MC38 tumor growth. PTPN22-IN-1 (syngeneic immunocompetent model; CT26 in Balb/c mice) shows similar antitumor effects[1].Administration of L-l intraperitoneally at 10 mg/kg yielded an average AUC of 4.55 μM h and Cmax of 1.1 1 μM (Fig. 9d), which is more than twice of its Ki value[1]. PTPN22-IN-1 (Compound L-1) (WT mice; intraperitoneally) significantly reduces MC38 tumor growth. PTPN22-IN-1 (syngeneic immunocompetent model; CT26 in Balb/c mice) shows similar antitumor effects[1].Administration of L-l intraperitoneally at 10 mg/kg yielded an average AUC of 4.55 μM h and Cmax of 1.1 1 μM (Fig. 9d), which is more than twice of its Ki value[1].

References

[1]. Elizabeth Jaffee, et al. Targeting ptpn22 in cancer therapy. WO2021007491A1.

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- Preparation Products And Raw materials

Raw materials

Preparation Products

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- Suppliers

Global( 1)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	28118	58

Supplier	Advantage
TargetMol Chemicals Inc.	58

3-Quinolinecarboxylic acid, 6-[[(2S)-2-[([1,1'-biphenyl]-4-ylcarbonyl)amino]-1-oxopropyl]amino]-1,4-dihydro-4-oxo- PTPN22-IN-1 (S)-6-(2-([1,1'-biphenyl]-4-ylcarboxamido)propanamido)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 2580935-57-3